Overall Technical outlook

Price Summary

Jubilant Pharmova Limited's stock spiked 2.62% today, reflecting an remarkablending market day.
On 2026-03-02, Jubilant Pharmova Limited's stock began at 828.6, climbed to 860.0, dropped to 825.1, and had 2.62% to end at 850.35, with a volume of 109605 shares.
The stock's highest value over the last 52 weeks is 1236.3, and the lowest value is 828.1.

Technicals


Aroon: Aroon's bearish trend remains strong, with Aroon Down still at the 100 level. This suggests ongoing downward pressure. However, this trend should be further explored using additional indicators to gain a clearer understanding of its long-term significance.
JUBLPHARMA aroon 66b8d1
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The current price for JUBLPHARMA has recently crossed above the lower Bollinger Band after previously trading below it. This movement suggests a potential shift in market sentiment, as the price has rebounded from an oversold condition. The upward crossover could indicate the beginning of a bullish trend or at least a temporary recovery, signaling that the downward momentum may be easing.
JUBLPHARMA bbands 66b8d1
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR has just moved from a bullish to a bearish stance, indicating a possible market downturn. If this shift is corroborated by other trends, it could be a very bearish signal. Investors should be cautious and look for additional confirmation before acting.
JUBLPHARMA psar 66b8d1
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
JUBLPHARMA stoch 66b8d1
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the potential for a reversal is hinted at by the slopes of the shorter-term averages. These faster-moving averages show signs of weakening momentum, indicating that while the overall trend is still upward, a reversal could be approaching.
JUBLPHARMA trippleSMA 66b8d1
Tripple SMA chart for Jubilant Pharmova Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.